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0. Summary 
 
The National Drugs Strategy (interim) 2009–2016 (NDS) provides the implementation framework for 
illicit drugs policy in Ireland. Overall responsibility for the NDS rests with the Minister for Health and 
the Minister of State in the Department of Health with responsibility for Drugs Strategy. The NDS 
strategic framework is constructed around a hierarchy of aims and objectives. The strategic 
direction is expressed in a single ‘overall strategic objective’: ‘To continue to tackle the harm caused 
to individuals and society by the misuse of drugs through a concerted focus on the five pillars of 
supply reduction, prevention, treatment, rehabilitation and research’.  
 
The NDS focuses on illicit drugs. However, Action 1 of the NDS called for the establishment of a 
Steering Group ‘to develop proposals for an overall Substance Misuse Strategy’, which would 
include both illicit drugs and alcohol. On foot of this report, the government approved a package of 
measures to deal with alcohol misuse.  
 
Implementation of the NDS is based on a ‘partnership’ approach, whereby over 20 government 
departments and statutory agencies, multiple service providers and community and voluntary 
groups work together through a nationwide network of regional and local drugs and alcohol task 
forces to deliver the NDS, with the statutory agencies critical in terms of core service provision. 
 
Early in 2015 the government released a Public Health (Alcohol) Bill, including a number of 
measures included in the report of the steering group on substance misuse, including:  
 minimum unit pricing for retailing of alcohol products,  
 regulation of marketing and advertising of alcohol,  
 structural separation of alcohol from other products in miked trading outlets,  
 enforcement powers to be given to Environmental Health Officers, and  
 health labelling to include warnings and advice. 
 
In 2015 the Department of Health published its annual progress report on implementation of the 
NDS. It shows that of the 63 actions, 29 have been completed; 20 are on the way to completion; 
and 12 have been delayed, some owing to the economic situation and some owing to the need for 
clarification to how to combine responses to illicit drugs and alcohol. 
 
In April 2015 a Minister of State for the Drugs Strategy was appointed in the Department of Health. 
Prior to this appointment, responsibility for drugs had rested with the Minister for Health since the 
Office of the Minister for Drugs was disbanded in 2011. The new Minister, Aodhán Ó Ríordáin TD, 
has indicated his interest in drug reforms such as the decriminalisation of drug use and the 
establishment in Dublin of a medically-supervised heroin injecting facility to address public injecting 
and associated harms. 
 
In November 2015 the Joint Committee on Justice, Defence and Equality released a report 
recommending a harm-reducing and rehabilitative approach to possession of small amounts of 
illegal drugs. 
 
The current NDS is due to expire at the end of 2016. The government is currently finalising its 
approach to reviewing the current strategy and developing a succeeding policy document. 
Organisations and groups have begun to prepare and/or issue submissions on the approach and 
the priorities that should be adopted in the next document. 
1. National profile  
1.1 National drugs strategies 
1.1.1 Current national drugs strategy 
The National Drugs Strategy (interim) 2009–2016 (NDS) provides the implementation framework for 
illicit drugs policy in Ireland (Department of Community 2009). Overall responsibility for the NDS 
rests with the Minister for Health and the Minister of State in the Department of Health with 
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responsibility for Drugs Strategy (see Sections 1.3 and 3.1 below for more detail on this recent 
appointment of a junior minister with responsibility for drugs strategy). Government departments 
with responsibility for implementing various actions in the NDS include Children and Youth Affairs; 
Education and Skills; Environment and Local Government; Health; Justice and Equality; and 
Transport. Statutory bodies with responsibility for implementing actions include the Courts Service; 
the Customs Service; An Garda Síochána; the Health Products Regulatory Authority (formerly the 
Irish Medicines Board); the Health Research Board; the Health Services Executive; the  Irish Prison 
Service; the Medical Bureau of Road Safety; the Probation Service; and the Road Safety Authority.  
 
The NDS strategic framework is constructed around a hierarchy of aims and objectives. The 
strategic direction is expressed in a single ‘overall strategic objective’: ‘To continue to tackle the 
harm caused to individuals and society by the misuse of drugs through a concerted focus on the five 
pillars of supply reduction, prevention, treatment, rehabilitation and research’. This overall strategic 
objective is cascaded down through five ‘overall strategic aims’ or pillars:* 
1. To create a safer society through the reduction of the supply and availability of drugs for illicit 
use (Supply Reduction); 
2. To minimise problem drug use throughout society (Prevention);  
3. To provide appropriate and timely substance treatment and rehabilitation services (including 
harm reduction services) tailored to individual needs (Treatment and Rehabilitation); 
4. To ensure the availability of accurate, timely, relevant and comparable data on the extent 
and nature of problem substance use in Ireland (Research); and 
5. To have in place an efficient and effective framework for implementing the NDS (Co-
ordination). 
 
These overall strategic aims, or pillars, are each fleshed out in a series of operational objectives and 
key performance indicators (KPIs). Finally, to ensure these operational objectives and KPIs are 
achieved, the NDS identifies 63 actions to be taken across the full range of government 
departments and agencies involved in delivering drugs policy.  
 
The NDS focuses on illicit drugs. However, Action 1 of the NDS called for the establishment of a 
Steering Group in autumn 2009 ‘to develop proposals for an overall Substance Misuse Strategy’, 
which would include both illicit drugs and alcohol. This steering group submitted a report on 
proposing a National Substance Misuse Strategy (NSMS) in 2012 (Department of Health 2012a), 
and on foot of this report, in October 2013 the government approved a package of measures to deal 
with alcohol misuse, to be incorporated in a Public Health (Alcohol) Bill, the General Scheme of 
which was published in 2015 (Department of Health 2015a). The main measures include:  
 minimum unit pricing for retailing of alcohol products,  
 regulation of marketing and advertising of alcohol,  
 structural separation of alcohol from other products in miked trading outlets,  
 enforcement powers to be given to Environmental Health Officers, and  
 health labelling to include warnings and advice.  
At the same time, the other measures set out in the NSMS were endorsed by the government and 
are being progressed by the relevant government departments and organisations.  More detail on 
these measures is given in Section T1.2.2 below. 
 
*No explanation is given in the NDS for the difference between the five ‘pillars’ listed in the overall 
strategic objective, and those listed as the ‘overall strategic aims’ 
 
1.1.2 Governance of drug issues 
Implementation of the NDS is based on a ‘partnership’ approach, whereby over 20 government 
departments and statutory agencies, multiple service providers and community and voluntary 
groups work together through a nationwide network of regional and local drugs and alcohol task 
forces (RDATFs and LDATFs) to deliver the NDS, with the statutory agencies critical in terms of 
core service provision. For more detail on drugs and alcohol task forces, see Section 1.3.1 below. 
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1.2 Evaluation of national drugs strategies 
1.2.1 Evaluations of national drugs strategies and supporting action plans 
Each year since 2012 the Department of Health has published a progress report on the 
implementation of the actions included in the NDS in the previous year. It is based on information 
provided by the various government departments and statutory agencies responsible for 
implementing the actions. The reports are as follows: 
 National Drugs Strategy 2009–2016: Progress report to end 2014 (Department of Health 2015b) 
 National Drugs Strategy 2009–2016: Progress report to end 2013 (Department of Health 2014) 
 National Drugs Strategy 2009–16: Implementation of actions progress report end 2012 
(Department of Health 2013) 
National Drugs Strategy 2009-16: implementation of actions progress report end 2011  (Department 
of Health 2012b) 
 
1.2.2 Results of the latest evaluation 
The progress report for 2014 provides a narrative account of progress against each action in 2014  
(Department of Health 2015b). Based on reading this report, an indication is given below of which 
actions under each pillar have been completed, where progress is being made, and where actions 
have been delayed or abandoned. Some actions may be included under more than one heading. 
 
Supply Reduction – 17 actions 
Under this pillar, most progress has been made in relation to local supply reduction initiatives, and 
compliance with EU-level obligations and operations. Work is under way in relation to several policy 
and legislative initiatives. Two capital projects have been put on hold owing to the difficult economic 
situation. 
 
Completed and/or ongoing: 11 
 Seven actions relating to local supply reduction initiatives have been largely completed, i.e. 
fostering community engagement through establishing appropriate drug networks, and  
ensuring drug issues are included in the work of Joint Policing Committees (Actions 2–4); 
developing frameworks for tackling drug-related intimidation in the community, and targeting 
adults in the drug trade who use children to engage in illegal drug-related activities (Actions 
5 & 7); improving drug-related security in prisons (Action 8); and the introduction of a 
presumptive drug testing regime (Action 12). 
 Five actions relating to EU-level obligations and operations (14–18), which involve 
monitoring and/or review of national legislation and policy or cooperation, are ongoing. 
Work in progress: 4 
 Drugs and driving (Action 9) – while the Medical Bureau of Road Safety (MBRS) has 
expanded its forensic analysis programme and provides training to the Gardaí, legislation to 
provide for roadside testing is still being developed (see Section T3.4 of Legal Framework 
workbook). The MBRS does not currently examine toxicology reports of all drivers involved 
in fatal road traffic accidents. 
 Licensing laws to combat sale or supply of alcohol to persons under the age of 18 (Action 
10) – the law in this area is subject to ongoing monitoring and review and, as noted in T1.1.1 
above, legislative changes are currently being developed. An Garda Síochána has 
established a working group to develop appropriate enforcement and prevention strategies. 
Two initiatives already implemented successfully are test purchasing of alcohol products, 
and a National Age Card. 
 Drug Court (Action 13) – on foot of two reviews of the Drug Treatment Court (in 2010 and 
2012/13), the Minister for Justice and Equality is examining options for the way forward in 
the context of wider justice reforms such as the proposal to establish a Community Court 
(see Section T2.2. in Legal Framework workbook).  
 Forensic Science Laboratory (Action 14) – permission has been given to fill four vacancies at 
senior level, including a Head of DNA. In 2014 an Implementation Group was established to 
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oversee the implementation of the Criminal Justice (Forensic Evidence and DNA Database 
System) Act 2014. 
Delayed: 2 
Implementation of two actions has been delayed owing to the current economic situation and 
budgetary constraints: 
 full development of an  integrated system to track the progression of offenders with drug-
related offences through the criminal justice system is subject to review  (Action 6), and 
 plans to build a new Forensic Science Laboratory have been put on hold (Action 14). 
 
Prevention – 13 actions 
Actions under this pillar relate to both illicit drugs and alcohol. Most progress has been made with 
regard to setting up education programmes and drug policies in schools, and with regard to youth 
interventions and facilities in out-of-school settings, and developing online prevention and help 
services. Work is under way developing programmes targeting families experiencing difficulties 
owing to drug/alcohol use and the children of drug users, and also selective prevention measures to 
reduce under-age and binge drinking.  
 
The adoption of the National Substance Misuse Strategy has led to a delay in the development of 
certain policy frameworks, standards and interventions – while the methodological approaches are 
re-assessed to ensure they are still appropriate 
 
Completed and/or ongoing: 7 
 Education programmes and drug policies in schools and recognised Centres of Education 
continue to be monitored improved (Actions 20, 21 and 23), and youth interventions and 
facilities in out-of-school settings continue to be developed (Actions 24 & 25). 
 A web site providing fully integrated information (drugs.ie) and access to a national helpline 
continue to be developed (Action 27). 
 Early school leaving (ESL) (Action 31) continues to be addressed by a range of supports in 
the DEIS Programme. A consolidated report on DEIS, incorporating the inputs, processes 
and educational outcomes contained in all research on DEIS conducted to date, is 
scheduled for completion in 2015.  
Work in progress: 3 
 In line with the call to develop ‘a sustained range of awareness campaigns’ (Action 28), the 
HSE  has supported a number of awareness initiatives relating to  the use of information and 
communications technology (ICT) in drugs and alcohol awareness initiatives, a designated 
drug/alcohol awareness week/day, and targeting third-level educational institutions, 
workplaces and recreational venues. 
 With regard to targeting families experiencing difficulties owing to drug/alcohol use and the 
children of drug users (Action 29), there has been a focus on ‘hidden harm’: 
o a national conference on the impact of parental problem alcohol and other drug use 
on children was held;  
o the national policy framework for children and young people 2014–2020 recognises 
the issue of Hidden Harm;  
o the HSE and TUSLA (the National Children’s Agency) are developing a strategic 
statement of intent for Hidden Harm, the objective being to bridge the gulf between 
drug and alcohol services and the child care system; and  
o a North/South Hidden Harm Group has been established to adopt an inter-sectoral 
response to Hidden Harm on an all-island basis. 
 Selective prevention measures to reduce under-age and binge drinking (Action 30) were 
progressed in 2014 by setting up a National Community Mobilisation Alcohol Pilot Project to 
support communities in identifying alcohol-related harm issues and priorities and developing 
appropriate responses, with a view to developing an integrated action plan to address the 
issues under each of the national priority headings as outlined in the National Substance 
Misuse Strategy (Department of Health 2012a). 
Delayed/abandoned: 3 
 A framework for the future design of targeted prevention and education interventions using a 
tiered approach (Action 19) and the feasibility of implementing a uniform set of drugs and 
7 
 
alcohol education standards (Action 26) are being reassessed in the context of 
recommendations in the National Substance Misuse Strategy. 
 Promotion of substance misuse policies and development of brief interventions in the 
informal education sector, tertiary institutions, workplaces, and youth, sport and community 
organisations (Action 22) have been superseded by actions in the National Substance 
Misuse Strategy. 
 
Treatment & Rehabilitation – 25 actions 
Treatment and rehabilitation services are developed on an ongoing basis, including expanding the 
range of both services available and the groups with specific needs being targeted. A clinical and 
organisational governance framework for all treatment and rehabilitation services has been 
developed.  
 
Work is reported to be well under way with regard to developing treatment guidelines for treating 
blood-borne viruses, and training programmes for all involved in the provision of substance misuse 
treatment services. Policies and procedures for referrals of under-18 service users who are showing 
signs of substance use, and for young people arrested by the Gardaí, are also being developed. In 
response to the issue of drug-related deaths, a naloxone demonstration project has been rolled out, 
but no progress is reported in relation to the development of a National Overdose Prevention 
Strategy or a review of the regulatory framework in relation to prescription drugs. 
 
A statutory regulatory framework for the provision of counselling within substance misuse services 
has been delayed because counselling is not one of the 12 health and social care professions 
designated under the Health and Social Care Professionals Act 2005. 
 
Completed and/or ongoing: 11 
 The development and improvement of the range, integration and availability of, and access 
to, treatment and rehabilitation services, e.g. initial and comprehensive assessments, 
Minnesota Programme, brief intervention, individual counselling, individual care plans 
including provision for dual diagnosis, detox facilities, methadone services and alternative 
substitute opiate treatment services, residential care, under-18s services, and needle 
exchange, are reported to be ongoing (Actions 32–35). 
 The treatment and rehabilitation needs of specific groups, i.e. families of drug users, service 
users and drug users, drug users in prisons, and vulnerable groups including travellers, 
LGBTs, new communities and sex workers, are reportedly being addressed on an ongoing 
basis (Actions 41–44). 
 A clinical and organisational governance framework for all treatment and rehabilitation 
services (Action 45) has been developed by the Quality Standards Support Project (QSSP) 
of the Ana Liffey Drugs Project with the support of the HSE. The resources and supports can 
be found on line at www.drugs.ie/quality  
Work in progress: 10 
 Training in line with the HSE’s Alcohol Screening and Brief Intervention Project is under way 
(Action 36). 
 Early identification and onward referral of under-18 service users who are showing signs of 
substance use (Action 37) will be developed on foot of the completion of actions in the 
National Strategy for Research and Data on Children’s Lives 2011–2016; specifically, 
actions relating to improved and increased use of data on alcohol and drugs in the lives of 
children, mining of data sources in relation to the interaction between drug use and youth 
offending, and increased dissemination of existing information on drug misuse among 
children and young people. 
 A ‘Pathways to Support’ programme has been developed incorporating a treatment referral 
option for young people arrested by the Gardaí (Action 38), and An Garda Síochána are 
examining how this programme will be implemented. 
 National clinical treatment guidelines for dealing with blood-borne viruses, especially 
hepatitis C, have been developed and the development of national hepatitis C screening 
guidelines is under way (Action 39). 
 In response to the issue of drug-related deaths (Action 40), a naloxone demonstration 
project has been rolled out in 2015. The project will be evaluated and the evaluation should 
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scope out the effectiveness of training and product use. No progress is reported in relation to 
the development of a National Overdose Prevention Strategy or a review of the regulatory 
framework in relation to prescription drugs. 
  Development of national training standards for all involved in the provision of substance 
misuse services and appropriate educational models for paramedics, nurses and midwives, 
and doctors, is progressing (Action 47 & 48). 
Delayed: 4 
 A regulatory framework on a statutory basis for the provision of counselling within substance 
misuse services (Action 46) has been delayed because counselling is not one of the 12 
health and social care professions designated under the Health and Social Care 
Professionals Act 2005. A statutory consultation process is now under way on the possible 
designation of counsellors and psychotherapists for regulation under the 2005 Act. 
 
Research & Information – 8 actions 
In line with the EU Early Warning System, a communication protocol for notification of drug use 
emergencies has been developed in Ireland.  The five key epidemiological indicators relating to drug 
use and the associated data collection systems are also all under continuous development. 
 
Work is under way on the development of indicators for harm reduction, public expenditure and 
drugs and crime, and of a system for monitoring problem substance (including alcohol) use among 
those presenting to hospital emergency departments, and on the roll-out of unique identifiers under 
the Health Identifiers Act 2014. 
While the National Advisory Committee on Drugs and Alcohol (NACDA) is currently overseeing a 
study to estimate the prevalence of children residing with substance-misusing parents, and two drug 
prevalence surveys, it has been unable to conduct the planned research on rehabilitation owing to 
lack of a researcher and a rehabilitation research budget. The reform of the Coroner Service has 
also had to follow a more gradual, cost-neutral approach owing to the difficult national economic 
situation.   
 
Completed and/or ongoing: 2 
 The five key epidemiological indicators relating to drug use (prevalence in general 
population, prevalence and patterns of use of specific drugs, drug treatment demand, drug-
related deaths and infectious diseases) and the associated data collection systems are all 
under continuous development (Action 49).  
 In line with the EU Early Warning System, a communication protocol for notification of drug 
use emergencies has been developed (Action 54). 
Work in progress: 3 
 The development of indicators for harm reduction, public expenditure and drugs and crime, 
of a system for monitoring problem substance (including alcohol) use among those 
presenting to hospital emergency departments, and the roll-out of unique identifiers under 
the Health Identifiers Act 2014, are all under way (Actions 50–52). 
Delayed: 3 
 The reform of the Coroner Service has had to follow a more gradual, cost-neutral approach 
owing to the difficult national economic situation (Action 53).  
 While the National Advisory Committee on Drugs and Alcohol (NACDA) is currently 
overseeing a study to estimate the prevalence of children of, or residing with, substance-
misusing parents, and the conduct of two drug prevalence surveys (in the general population 
and the prevalence of opioid use), it has been unable to conduct rehabilitation research 
owing to lack of a researcher and a rehabilitation research budget. Work on disseminating 
research findings and models of best practice has also been hampered by lack of research 
staff and a reduced budget (Actions 55 & 56). 
 
Co-ordination – 7 actions 
Completed and/or ongoing: 4 
 The Oversight Forum on Drugs (OFD) has been established (Action 58). See Section T1.3.1 
below for an outline of the role of the OFD. 
 A performance management framework for the NDS is maintained by the Department of 
Health by means of the OFD process and by compiling an annual report on progress in 
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implementing the actions in the NDS, based on reports submitted by the various government 
departments and statutory agencies. This report can be found at 
http://www.drugsandalcohol.ie/23935/ (Action 59). 
 To ensure a more co-ordinated approach to supporting Ireland’s international role and 
responsibilities in relation to problem drug use, protocols between relevant departments and 
agencies have been put in place and the relevant departments and agencies meet on an 
ongoing basis (Action 61).  
 In line with the 2012 report on the review of drugs task forces, the National Co-ordinating 
Committee on Drugs and Alcohol Task Forces (NCC) has agreed new terms of reference for 
task forces, provided guidance on how task forces can implement the National Substance 
Misuse Strategy and has requested details of the measures task forces need to take to 
comply with rules on election of members. A sub-group has also been established to 
strengthen the mechanisms for measuring the impact of task forces (Action 62). 
Work in progress: 1 
 Task forces have inclusive service provision policies but there is a need for more formal 
representation from at-risk groups (e.g. travellers, new communities, LGBTs, homeless 
people and sex workers) through CityWide to inform policy and design interventions. A sub-
group of the NCC (see Section 1.3.1 below for outline of the role of the NCC) is currently 
reviewing the level of engagement with travellers (Action 60).  
Delayed/abandoned: 2 
 The Office of the Minister of Drugs was established in 2010 but a year later was subsumed 
into the Department of Health (Action 57). 
It was decided not to establish a dedicated treatment agency for drugs (Action 63). 
1.3  Drug policy coordination 
1.3.1 Coordination bodies involved in drug policy 
 
The Minister for Health has overall responsibility for the NDS. A Minister of State with 
responsibility for the Drugs Strategy is located within the Department of Health. Currently this 
Minister of State also has responsibility for the Equality portfolio within the Department of Justice 
and Equality (see Section 3.1 below for further detail).  
 
 An Oversight Forum on Drugs (OFD), chaired by the Minister of State with responsibility for the 
Drugs Strategy, and comprising senior representatives of the various government departments and 
statutory agencies involved in delivering on the NDS, and representatives from the community and 
voluntary sectors, meets every quarter to monitor progress and address any operational issues.  
 
A National Co-ordinating Committee for Drug and Alcohol Task Forces (NCC) drives 
implementation of the NDS at the local and regional level. It is responsible for making 
recommendations to the Minister of State with responsibility for the Drugs Strategy in relation to the 
implementation of the NDS. The committee is chaired by a senior official in the Department of 
Health, with membership consisting of two representatives of each of the four networks – the 
LDATF Chairs, the LDATF Coordinators, the RDATF Chairs and the RDATF Coordinators; 
representatives of the key Departments and agencies involved in the implementation of the NDS; 
and two community-sector representatives and two voluntary- sector representatives. 
 
Local and Regional Drug and Alcohol Task Forces (L/RDATFs) play a key role in assessing the 
extent and nature of the drug problem in their areas and coordinating action at local level so that 
there is a targeted response to the drug problem in local communities. They implement the NDS in 
the context of the needs of their region or local area through action plans which have identified 
existing and emerging gaps in the following areas: 
 Supply reduction, 
 Prevention, 
 Treatment, 
 Rehabilitation, and 
 Research. 
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Drug and alcohol task forces comprise representatives from a range of relevant agencies, such as 
the HSE, the Gardaí, the Probation Service, Education and Training Boards, local authorities, the 
Youth Service, as well as elected public representatives and voluntary- and community-sector 
representatives. 
 
LDATFs were originally set up in areas with the highest levels of drug misuse.  Following the 
establishment of Regional Drugs and Alcohol Task Forces (RDATFs) under the first National Drugs 
Strategy (2001–2008), all areas of the country are covered by a drug and alcohol task force. There 
are 14 LDATFs and 10 RDATFs. 
 
1.4 Drug related public expenditure 
1.4.1 Data on drug-related expenditure 
Each year the Department of Health, in its role as coordinator of the implementation of the National 
Drugs Strategy 2009–2016 (NDS), requests government departments and state agencies with 
responsibilities for implementing actions in the NDS to submit a report on their drug-related 
expenditure in the current year, broken down according to the COFOG values (1st and 2nd levels).  
 
According to Sections 1.4.1–1.4.2 of last year’s National Report on the drug situation and responses 
in Ireland, while direct public expenditure on the drugs issue had decreased by 15% between 2009 
and 2013, in 2014 it began to show a small increase compared to the previous year. 
1.4.2 Breakdown of estimates of drug related public expenditure. 
Details of the expenditure attributable to drugs programmes by government department/agency 
from 2009 to date, as well as the estimated allocation for 2015, are outlined in Table 1.4.2.1. In the 
six years since 2009, drug-related expenditure in Ireland has declined by 16%; however, in 2015 
expenditure stayed at the same level as in the previous year. 
Commenting on the figures for the past seven years, the Minister with responsibility for the Drugs 
Strategy, Aodhán Ó Ríordáin, stated that the decrease in HSE expenditure in 2011 compared to 
2010 arose because of savings made as a result of the public service pay cut, HSE staffing 
redundancies and a reduction in funding to voluntary and community agencies. Further savings 
were identified by the HSE in 2014 and these were taken into account in determining the 2015 
allocation. The reduction in the Department of Health allocations in 2014 and 2015 reflects the fact 
that the Department transferred €21.04m in funding relating to Drugs and Alcohol Task Force 
projects to the HSE on 1 January 2014, with a further €1.02m transferring on 1 January 2015 (Ó 
Ríordáin 2015). 
Table 1.4.2.1  Public expenditure directly attributable to drug programmes, 2009–2015 
Department/Agency 
2009 
(€m) 
2010 
(€m) 
2011 
(€m) 
2012 
(€m) 
2013 
(€m) 
2014 
(€m) 
2015 
(€m) 
HSE Addiction Services 104.867 105.400 92.878 89.368 90.392 86.122 86.279 
HSE Drugs and Alcohol Task Force Projects 0 0 0 0 0 21.570 22.593 
An Garda Síochána 45.004 44.500 45.014 45.850 44.000 43.000 43.000 
D/Children & Youth Affairs 28.501 25.740 24.987 22.730 20.310 19.548 19.548 
D/Justice & Equality 14.801 14.478 18.681 18.580 18.553 18.762 18.928 
Revenue Customs Service 15.867 15.797 15.470 14.241 14.624 16.235 16.235 
D/Social Protection (former FÁS area) 18.800 18.000 15.634 11.859 13.434 14.063 13.702 
D/Health 40.326 35.755 33.554 32.376 30.524 8.280 7.350 
Irish Prison Service 5.000 5.200 5.200 5.000 4.500 4.200 4.285 
D/Education & Skills 3.643 2.461 0.411 0.815 0.810 0.748 0.746 
D/Environment, Community & Local 
Government 
0.461 0.461 0.400 0.200 0 0 0 
Total 277.270 267.792 252.229 241.019 237.147 232.528 232.666 
Source: Ó Ríordáin, 1 July 2015 
The break-down of drug-related public expenditure in 2015 by COFOG classifications is provided in 
Table 1.4.2.2. Total expenditure is €232.422 million, which is €244,000 less than the total shown in 
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Table 1.4.2.1 above: the data in Table 1.4.2.2 were assembled earlier in the year than the data 
presented in Table 1.4.2.1. 
Table 1.4.2.2. Break-down of drug related public expenditure 
Expenditure 
€m 
Year COFOG 
classification 
National accounting 
classification 
Trace 
(Labelled, 
Unlabelled) 
Comments 
      
0.614 2014 gf07.05 Department of Health: 
Health Research 
Board 
Labelled Research and 
reports in 
relation to drug 
services and 
drug-related 
deaths 
0.294 2014 gf07.05 Department of Health: 
Health Research 
Board 
Labelled National 
Documentation 
Centre 
0.365 2014 gf07.05 Department of Health: 
National Advisory 
Committee on Drugs 
and Alcohol 
Labelled Research and 
advisory 
function of the 
NACDA 
4.994 2014 gf07.02 Department of Health: 
Local Drugs Task 
Forces 
Labelled Treatment and 
rehabilitation 
services 
provided to 
drug users 
1.459 2014 gf07.02 Department of Health: 
Regional Drugs Task 
Forces 
Labelled Treatment and 
rehabilitation 
services 
provided to 
drug users 
0.209 2014 gf07.04 Department of Health: 
Citywide 
Labelled National 
network of 
community 
activists and 
community 
organisations 
0.170 2014 gf07.04 Department of Health: 
National Family 
Support Network 
Labelled Supports the 
development 
of family 
support groups 
throughout the 
country 
0.008 2014 gf07.04 Department of Health: 
Dial-to-Stop Drug 
Dealing 
Labelled Free phone 
service to 
report drug 
dealing and 
drug-related 
crime 
0.061 2014 gf07.06 Department of Health: 
Other 
Labelled Other 
miscellaneous 
activities 
18.397 2014 gf 08.01 Department of 
Children & Youth 
Affairs: Young 
People’s Facilities & 
Services Fund 
(rounds 1 and 2) 
Labelled Youth 
programmes 
with drug-
specific 
initiatives 
1.151 2014 gf08.01 Department of 
Children & Youth 
Affairs: Local Drugs 
Task Force projects 
Labelled Mainstreamed 
drugs projects 
0.393 2014 gf09.05 Department of 
Education & Skills: 
Local Drugs Task 
Force area projects 
Labelled Drug 
education & 
prevention 
projects 
0.355 2014 gf09.05 Department of 
Education & Skills: 
Drug Court – 
Labelled Drug Court – 
education 
support 
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education support 
58.761 2014 gf07.04 Health Service 
Executive: Drug-
related health 
services 
Labelled Drug-related 
health services 
21.570 2014 gf07.02 Health Service 
Executive: Drugs 
Task Force projects 
Labelled Treatment and 
rehabilitation 
services 
provided to 
drug users 
7.395 2014 gf07.04 Health Service 
Executive: National 
Drug Treatment 
Service 
Labelled Drug-related 
health services 
19.966 2014 gf07.04 Health Service 
Executive: Primary 
Care Reimbursement 
Service 
Labelled Drug-related 
health services 
13.463 2014 gf10.05 Department of Social 
Protection: 
Community 
Employment (CE) 
Programme 
Labelled Training and 
rehabilitation 
places for 
drugs-referred 
clients on CE 
schemes 
0.600 2014 gf10.07 Department of Social 
Protection: Local 
Drugs Task Force 
mainstream projects 
Labelled Support for 
community-
based drugs 
projects 
0.124 2014 gf03.03 Department of Justice 
& Equality: Courts 
Service – public order 
& safety 
Labelled Drug 
Treatment 
Court 
0.136 2014 gf07.05 Department of Justice 
& Equality: Health 
Research Board – 
Health 
Labelled Research on 
drug-related 
deaths 
1.595 2014 gf07.06 Department of Justice 
& Equality: Probation 
Service – Health 
Labelled Community-
based 
rehabilitation 
services 
16.907 2014 gf09.06 Department of Justice 
& Equality: Irish 
Youth Justice Service 
– Education  
Labelled Youth crime 
diversion 
programmes 
4.200 2014 gf03.04 Department of Justice 
& Equality and Health 
Service Executive: 
Irish Prison Service 
Labelled Drug treatment 
services in 
prisons 
43.000 2014 gf03.01 Department of Justice 
& Equality: Garda 
Síochána  
Labelled Policing & 
investigation 
costs 
16.235 2014 gf03.01 Revenue, Irish Tax & 
Customs: Customs 
Service 
Labelled Supply 
reduction – 
border policing 
(anti-
smuggling) 
Source: Unpublished data, Drugs Policy Unit, Department of Health, October 2015 
 
 
2. New developments  
 
2.1 Developments in drug policy 
In April 2015 Aodhán Ó Ríordáin TD was appointed Minister of State for the Drugs Strategy in the 
Department of Health. He is also Minister of State with responsibility for New Communities, Culture 
and Equality, which brief is spread across the Department of Justice and Equality and the 
Department of Arts, Heritage and the Gaeltacht. Prior to his appointment, responsibility for drugs 
had rested with the Minister for Health since 2011, when the Office of the Minister for Drugs was 
disbanded. 
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Minister for Health Leo Varadkar welcomed the appointment, commenting ‘There is a lot of merit in 
appointing a cross-Departmental Minister for Drugs, as there is a significant overlap between Health 
and Justice in this area, ranging from treatment and prevention to enforcement and diversion. The 
new role will bring together the work and actions of the HSE and Gardaí among others.’ Minister 
Varadkar also noted the new Minister’s commitment to the equality agenda and his ‘excellent track 
record of community work’. 
 
New Minister supports drug policy reforms  
On 2 November 2015 Minister Aodhán Ó Ríordáin gave the keynote address at a meeting of the 
London School of Economics IDEAS International Drug Policy Project (Ó Ríordáin A 2015a). Having 
outlined the history of the drug problem in Ireland and policy responses, he outlined his views in 
favour of two new harm-reduction options. 
 
Medically-supervised injecting facilities 
‘Addiction is not a choice, it’s a healthcare issue. This is why I believe it is imperative that we 
approach our drug problem in a more compassionate and sensitive way. One of the key 
things that I aim to achieve during my remaining time in office is the introduction of a 
medically supervised injecting centre for intravenous drug users. … I have asked officials in 
my Department to examine proposals for the provision of medically supervised injecting 
facilities as a response to this issue. This is in line with similar models in Sydney and parts of 
Europe. 
‘Research has shown that the use of supervised injecting centres is associated with self-
reported reductions in injecting risk behaviours that increase risk of blood-borne virus 
transmission, overdose and death. The impact of injecting centres on the reduction of HIV or 
hep C virus incidence among the wider population of intra-venous drug users remains 
unclear. However, as the recent spike in blood-borne viruses in Dublin was among those 
who are most likely to avail of supervised injecting facilities, I hope that the introduction of 
these facilities may reduce the risk of future spikes occurring.’ 
 
Decriminalisation 
‘Since taking up my new role as Minister for Drugs, I have spoken to a lot of people who 
would like to see a more compassionate approach to those who experience drug problems. 
Too often those with drug problems suffer from stigma, due to a lack of understanding or 
public education about the nature of addiction. This stigma can be compounded for those 
who end up with a criminal record due to possession of drugs for their own use. 
‘It is against this background that there is now an emerging debate in Ireland on whether an 
alternative approach to the possession of small quantities of illicit drugs for personal use 
should be considered. 
 
‘I am in favour of a decriminalisation model, but it must be one that suits the Irish context and 
it must be evidence-based.   I believe that this kind of approach will only work if it is 
accompanied by timely treatment and harm reduction services, backed up by wrap-around 
supports which foster recovery – such as housing, health and social care.   Above all, the 
model must be person-centred and involve an integrated approach to treatment and 
rehabilitation based on a continuum of care with clearly defined referral pathways.’ 
 
Oireachtas (Parliamentary) Committee recommends a harm-reducing and rehabilitative 
approach to possession of small amounts of illegal drugs 
On 5 November 2015 the Joint Committee on Justice, Defence and Equality released a report 
recommending a harm-reducing and rehabilitative approach to possession of small amounts of 
illegal drugs (Joint Committee on Justice 2015). In June 2015, a delegation of the Committee visited 
the EMCDDA in Portugal and engaged extensively with Portuguese authorities on the approach to 
drug addiction adopted there since 2001.  On return from Portugal, the delegation proposed that the 
Committee investigate the adoption of a similar model to the Portuguese approach in Ireland.  The 
Committee has concluded that there is merit in further exploring the Portuguese model and in 
examining how it may be adapted for use in an Irish context. The Committee suggests that a 
health/counselling/ treatment approach may be more effective and more appropriate for those found 
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in possession of a small amount of illegal drugs for personal use rather than imposing a criminal 
sanction resulting in a lifelong criminal record.  
 
Specific recommendations include: 
1. The Committee strongly recommends the introduction of a harm reducing and rehabilitative 
approach, whereby the possession of a small amount of illegal drugs for personal use, could be 
dealt with by way of a civil/administrative response and rather than via the criminal justice route. 
2. The Committee recommends that discretion for the application of this approach would remain 
with An Garda Síochána/Health Providers in respect of the way in which an individual in possession 
of small amounts of drugs for personal use might be treated. 
3. The Committee recommends that any harm reducing and rehabilitation approach be applied on a 
case-by-case basis, with appropriately resourced services available to those affected, including 
resources for assessment (e.g. similar to the Dissuasion Committees used in Portugal) and the 
effective treatment of the individuals concerned. 
4. The Committee draws attention to the success of ‘informal’ interaction with users when referred to 
the ‘Dissuasion Committees’ in Portugal and recommends that such an approach should be 
employed in Ireland if the recommendations in this report are to be adopted. 
5. The Committee recommends that resources be invested in training and education on the effects 
of drugs and that appropriate treatment be made available to those who need to avail of same. The 
Committee feels that out-of-school ‘informal’ interaction by Youth Services could have a major role 
to play in this context. 
6. The Committee recommends that research be undertaken to ensure that the adoption of any 
alternative approach be appropriate in an Irish context. 
3. Additional information 
3.1 Additional important sources of information 
Two papers critically examining aspects of Ireland’s current approach to alcohol and drug policy 
were published during 2015.  
 
‘Ireland’s Public Health (Alcohol) Bill: policy window or political sop?’  
Against a historical backdrop of previous alcohol policy proposals in Ireland in recent decades, 
Shane Butler has written an article titled ‘Ireland’s Public Health (Alcohol) Bill: policy window or 
political sop?’, which looks critically at recent developments in alcohol policy (i.e. the Steering Group 
report on a National Substance Misuse Strategy and the government decision to approve a number 
of alcohol policy measures to be incorporated into a Public Health [Alcohol] Bill). He sought to 
determine to what extent it represents, in Kingdon’s terms, a ‘policy window’ for the public health 
approach to alcohol issues (Butler S 2015). Butler argues that while some specific public health 
measures may be introduced, the various ‘streams’ of the Irish policy process have not joined 
together in an unambiguous, consensual acceptance of the public perspective on alcohol, and that 
the ‘politics stream’ has not to date deemed this perspective to be consonant with the ‘national 
mood’. 
 
‘Drug use trends: static drug policies’ 
Aileen O’Gorman gave a paper at the 2015 annual conference of the International Society for the 
Study of Drug Policy (ISSDP) based on a study of licit and illicit drug use patterns in the Finglas–
Cabra local drugs task force area in Dublin, undertaken in the second half of 2012 (O'Gorman, et al. 
2013). The conference paper was titled ‘Changing drug trends: static drug policies’.  The abstract of 
O’Gorman’s paper, printed below, is from the book of ISSDP conference paper abstracts. 
 
Background 
Since the 1990s, patterns and trends in drug consumption have evolved in response to global and 
local shifts in drug production and supply, and in fluctuating levels of demand influenced by 
accessibility, price, quality, and cultural appeal. The consumption of a combination of licit and illicit 
substances has become a regular feature of weekend and festive socialising among young people. 
‘Illegal leisure’ had become normalised and accommodated into the social and cultural practices of 
different social groups (citations deleted), albeit on a differentiated basis (citations deleted). 
15 
 
Nonetheless, internationally, drug policy remains predominantly and intransigently prohibitionist, 
focused on criminalising users, curtailing supply, and preventing and treating addictions. The gap 
between drug policies and drug consumption practices is ever widening. 
 
Aims and methods 
This paper draws from the findings of a recent neighbourhood study that explored drug consumption 
patterns, practices and meanings from the perspective of a group of young people ‘from the street’ 
whose public presence was often perceived as problematic and who were regarded as being ‘at 
risk’ through their drug use (citation deleted). Data were collected through individual and focus 
groups interviews, and ethnographic observations and conversations in the drug users’ natural 
locations. The paper is further informed by a series of neighbourhood drug studies, which began in 
Dublin in 1996 and have been conducted at intervals since (citations deleted). These studies share 
a similar critical interpretivist methodological approach, which explored the lived experience of these 
drug users within a political economy framework of analysis of socio-spatial risk environments.  
 
Findings  
Patterns emerged from the drug enthusiasts’ narratives illustrating how drug consumption practices 
were shaped by different intentions mediated by time and space settings, and the negotiation of an 
intricate interplay between structure and agency. Drug intentions were a key influence on their 
consumption practices. These intentions ranged from ‘chillin’, ‘buzzin’, ‘getting mangled’, and 
‘coming down’ and each intention was embedded in a set of polydrug combinations that included 
alcohol, cannabis, ecstasy, cocaine, new psychoactive substances, and prescription tablets (mainly 
benzodiazepines and so called ‘Z drugs’ such as Zimovane, Zopiclone etc.). 
The paper describes and analyses their drug choices, intentions, and risks and situates them in the 
context of the role and meaning drug use, and their participation in the drugs economy, play in their 
lives. Glimpses of rational action and cost-benefit analyses in their discourses of choice were seen 
to be brokered within short-term socio-temporal spaces and bounded by the broader social, cultural 
and policy contexts they inhabit. Drug users do not exist in isolation from their social, economic and 
policy contexts. The findings of this study highlight the need for integrated drug and social policies 
that address broader contextual structural issues and inequalities. 
 
4. Notes and queries 
4.1 Planned evaluations 
The National Drugs Strategy is due to expire at the end of 2016. Appearing before a joint sitting of 
the joint parliamentary committees on Health and Children and on Justice, Defence and Equality in 
July 2015, Minister Aodhán Ó Ríordáin TD stated: ‘ … as Minister with responsibility for the national 
drugs strategy, I will be leading the development of the drugs strategy for the period after 2016. My 
intention over the coming months is to lay the groundwork for a concise and focused policy, placing 
a clear emphasis on the practical implementation of actions. An examination of the approach to 
drugs policy and practice in other jurisdictions will also help to identify any additional evidence-
based approaches which might be considered in an Irish context. The development of the new 
strategy gives us the opportunity to have a constructive and wide-ranging public dialogue on our 
current drug policies so that we are in a strong position to develop a fit-for-purpose response to the 
drug problem which will meet challenges into the future.’ (Ó Ríordáin A 2015b) 
Organisations and groups in Ireland have begun to prepare and/or issue submissions on the 
approach and the priorities that should be adopted in the next document. For example, Citywide 
Drugs Crisis Campaign is holding a conference on 12 November 2015 to highlight the issue of drug 
law reform in the run-up to UNGASS 2016 and the preparation of the new national drugs strategy. 
Position papers have been developed by the Irish Medical Organisation (Irish Medical Organisation 
(IMO) 2015), the Fianna Fáil political party (Frances Fitzgerald 2015) and SAOL, an integrated 
programme of education, rehabilitation, advocacy and childcare working with women drug users and 
their children (Pike B 2015).  
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4.2 Estimate of the contribution of the illicit drug market to the National Accounts provided  
to EUROSTAT  
To comply as far as possible with the Eurostat requirement, the revised and additional estimates for 
illegal activities for Ireland were included in CSO's Quarterly National Accounts (QNA) in respect of 
Q1 2014 and the annual National Income & Expenditure accounts (NIE) 2013 (personal 
communication, Pat Kilduff, CSO, August 2014).  
5. Sources, methodology and references 
5.1 Sources 
National Drugs Strategy 
 
Public Health (Alcohol) Bill 2015 
 
National Drugs Strategy 2009-2016: progress report to end 2014 
 
Steering Group Report on a National substance misuse strategy 
 
National Advisory Committee on Drugs and Alcohol 
 
5.2 Methodology 
O'Gorman, A., et al. (2013). An analysis of current licit and illicit drug use patterns in the 
Finglas-Cabra local drugs task force area. Dublin, Finglas/Cabra Local Drugs Task Force. 
 
The research methodology employed in this study was based on a community and participatory 
research methodology developed by the Principal Investigator for a module in Community Research 
Methods on the UCD Diploma in Community Drugs Work. The research was conducted by the 
Principal Investigator and a team of privileged access community researchers who were graduate 
students of this Diploma – a programme undertaken in partnership with the URRUS (community 
education) project in Ballymun, as part of the Drugs Education and Research Initiative in the UCD 
School of Applied Social Science.  
 
The research methodology was a sociologically grounded mixed-method approach, based on the 
collection and analysis of quantitative and qualitative data drawn from a variety of information 
sources. The approach used induction and triangulation to validate and cross-check data in order to 
arrive at an in-depth understanding of local drug use patterns and to develop a typology of local 
drug users and their consumption practices. The approach was underpinned by a participatory 
research methodology, designed to minimise the power relationship between the observer and the 
observed, and to maximise understanding of the lived experience of drug use from the users’ 
perspective. 
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European Monitoring Centre for Drugs and Drug Addiction 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is a decentralised EU 
agency based in Lisbon.  The EMCDDA provides the EU and its Member States with information on 
the nature, extent, consequences and responses to illicit drug use. It supplies the evidence base to 
support policy formation on drugs and addiction in both the European Union and Member States.   
There are 30  National Focal Points that act as monitoring centres for the EMCDDA.  These focal 
points gather and analyse country data according to common data-collection standards and tools 
and supply these data to the EMCDDA. The results of this national monitoring process are supplied 
to the Centre for analysis, from which it produces the annual European drug report and other 
outputs. 
 
The Irish Focal Point to the EMCDDA is based in the Health Research Board.  The focal point 
writes and submits a series of textual reports, data on the five epidemiological indicators and supply 
indicators in the form of standard tables and structured questionnaires on response-related issues 
such as prevention and social reintegration.  The focal point is also responsible for implementing 
Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new 
psychoactive substances. 
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